Aducanumab Titration Dosing Regimen: 24-Month Analysis From Prime, A Randomized, Double-Blind, Placebo-Controlled Phase 1b Study In Patients With Prodromal Or Mild Alzheimer'S Disease

NEUROLOGY(2018)

引用 3|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要